Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Zuckerman

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
American Journal of Physiology. Renal Physiology|June 23, 2017
Store-operated calcium entry suppressed the TGF-β1/Smad3 signaling pathway in glomerular mesangial cellsSarika Chaudhari, Weizu Li, Yanxia Wang, et al.
Transplantation|August 1, 2023
Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical OutcomesMeghan H Pearl, Lucia Chen, Jonathan E Zuckerman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2016
CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosingAndrew J Clark, Devin T Wiley, Jonathan E Zuckerman, et al.
SAGE Open Medical Case Reports|July 24, 2020
Finding of pathological thrombomodulin gene variant in a patient with idiopathic nodular glomerulosclerosis and chronic thrombotic microangiopathy-like changesRamy Hanna, Jonathan E Zuckerman, Antoney Ferrey, et al.
American Journal of Physiology. Renal Physiology|March 17, 2017
Negative regulation of Smad1 pathway and collagen IV expression by store-operated Ca<sup>2+</sup> entry in glomerular mesangial cellsPeiwen Wu, Yuezhong Ren, Yuhong Ma, et al.
Case Reports in Nephrology and Dialysis|May 12, 2021
Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case ReportEverardo Arias Torres, Yongen Chang, Sheetal Desai, et al.
Clinical and Experimental Nephrology|December 18, 2025
Obesity-related glomerulopathy, A growing kidney burden in the obesity pandemicMahtab Mashayekhi, Jonathan E Zuckerman, Sahar H Koubar, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNAJonathan E Zuckerman, Ismael Gritli, Anthony Tolcher, et al.
Heart Rhythm|June 28, 2021
Aorticorenal ganglion as a novel target for renal neuromodulationYuichi Hori, Taro Temma, Christian Wooten, et al.
Nature|March 23, 2010
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesMark E Davis, Jonathan E Zuckerman, Chung Hang J Choi, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
American Journal of Physiology. Renal Physiology|June 23, 2017
Store-operated calcium entry suppressed the TGF-β1/Smad3 signaling pathway in glomerular mesangial cellsSarika Chaudhari, Weizu Li, Yanxia Wang, et al.
Transplantation|August 1, 2023
Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical OutcomesMeghan H Pearl, Lucia Chen, Jonathan E Zuckerman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 23, 2016
CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosingAndrew J Clark, Devin T Wiley, Jonathan E Zuckerman, et al.
SAGE Open Medical Case Reports|July 24, 2020
Finding of pathological thrombomodulin gene variant in a patient with idiopathic nodular glomerulosclerosis and chronic thrombotic microangiopathy-like changesRamy Hanna, Jonathan E Zuckerman, Antoney Ferrey, et al.
American Journal of Physiology. Renal Physiology|March 17, 2017
Negative regulation of Smad1 pathway and collagen IV expression by store-operated Ca<sup>2+</sup> entry in glomerular mesangial cellsPeiwen Wu, Yuezhong Ren, Yuhong Ma, et al.
Case Reports in Nephrology and Dialysis|May 12, 2021
Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case ReportEverardo Arias Torres, Yongen Chang, Sheetal Desai, et al.
Clinical and Experimental Nephrology|December 18, 2025
Obesity-related glomerulopathy, A growing kidney burden in the obesity pandemicMahtab Mashayekhi, Jonathan E Zuckerman, Sahar H Koubar, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNAJonathan E Zuckerman, Ismael Gritli, Anthony Tolcher, et al.
Heart Rhythm|June 28, 2021
Aorticorenal ganglion as a novel target for renal neuromodulationYuichi Hori, Taro Temma, Christian Wooten, et al.
Nature|March 23, 2010
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesMark E Davis, Jonathan E Zuckerman, Chung Hang J Choi, et al.
Pageof 8